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Abstract
Background: Tuberculosis (TB) remains one of the most important infectious diseases worldwide.
A comprehensive approach towards disease control that addresses social factors including stigma is now
advocated. Patients with TB report fears of isolation and rejection that may lead to delays in seeking care and
could affect treatment adherence. Qualitative studies have identified socio-demographic, TB knowledge, and
clinical determinants of TB stigma, but only one prior study has quantified these associations using formally
developed and validated stigma scales. The purpose of this study was to measure TB stigma and identify factors
associated with TB stigma among patients and healthy community members.
Methods: A cross-sectional study was performed in southern Thailand among two different groups of participants:
480 patients with TB and 300 healthy community members. Data were collected on socio-demographic
characteristics, TB knowledge, and clinical factors. Scales measuring perceived TB stigma, experienced/felt TB
stigma, and perceived AIDS stigma were administered to patients with TB. Community members responded to a
community TB stigma and community AIDS stigma scale, which contained the same items as the perceived stigma
scales given to patients. Stigma scores could range from zero to 30, 33, or 36 depending on the scale. Three
separate multivariable linear regressions were performed among patients with TB (perceived and experience/felt
stigma) and community members (community stigma) to determine which factors were associated with higher
mean TB stigma scores.
Results: Only low level of education, belief that TB increases the chance of getting AIDS, and AIDS stigma were
associated with higher TB stigma scores in all three analyses. Co-infection with HIV was associated with higher TB
stigma among patients. All differences in mean stigma scores between index and referent levels of each factor
were less than two points, except for incorrectly believing that TB increases the chance of getting AIDS (mean
difference of 2.16; 95% CI: 1.38, 2.94) and knowing someone who died from TB (mean difference of 2.59; 95% CI:
0.96, 4.22).
Conclusion: These results suggest that approaches addressing the dual TB/HIV epidemic may be needed to
combat TB stigma and that simply correcting misconceptions about TB may have limited effects.
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Background
Tuberculosis (TB) remains one of the most important
infectious diseases worldwide with an estimated 9.4 mil-
lion new cases and 1.7 million deaths in 2009 [1]. In addi-
tion to the focus on treatment and cure rates, a more
comprehensive approach towards disease control is now
advocated, in order to address poverty and other social
risk factors, of which stigma is one component [2]. Stigma
was originally described by Goffman as “an undesirable or
discrediting attribute that an individual possesses, thus
reducing that individual’s status in the eyes of society” [3].
More recently, health related stigma has been defined as
“a social process or related personal experience character-
ized by exclusion, rejection, blame, or devaluation that
results from experience or reasonable anticipation of an
adverse social judgment about a person or group identified
with a particular health problem” [4]. This conceptualiza-
tion highlights two important components of stigma: overt
patient experiences of discrimination in their community
and the internalized fear and anticipation of social conse-
quences regardless of any actual experience by the patient.
Defining stigma as a “social process” draws attention to
the important interactions between those who have the
“health problem” (e.g. patients with TB) and those who do
not (e.g. healthy community members)[5].
Individuals diagnosed with TB report fears of isolation
and rejection such as losing employment, being divorced
or having diminished marriage prospects, not being
allowed to share meals, utensils or sleeping quarters with
family members, and general avoidance or gossip among
community members [6-9]. Fear of these consequences
may lead to delays in seeking care for TB symptoms and
could affect adherence to treatment [6,7,10]. Because of
this, TB stigma continues to be viewed as a barrier to TB
control.
Qualitative studies using focus groups and interviews
have identified religion, socioeconomic status, level of edu-
cation, and gender as possible factors associated with TB
stigma [11,12], with women more often than men feeling
the effects of TB stigma [6,8]. Reasons why TB may be
stigmatizing include contagiousness [7,13,14], incorrect
knowledge of its cause, transmission, or treatment
[7,8,12,13,15], or its association with marginalized groups
such as the poor, ethnic minorities, sex workers, prisoners,
and those infected with HIV [7,8,12,13,16,17]. As the epi-
demics of TB and HIV/AIDS have converged in many
areas of the world, there is growing concern that AIDS
and AIDS stigma may compound existing TB stigma
[13,18,19]. For some, a TB diagnosis is thought to be
synonymous with an AIDS diagnosis, or TB symptoms
may be misidentified as AIDS symptoms [12,14,18-20].
While qualitative studies help identify possible factors
associated with stigma, quantitative measures are needed
to assess the level of stigma in a population, factors
most strongly associated with stigma, and evaluate the
effectiveness of interventions [4]. Unfortunately, few
quantitative studies have been done to assess factors
associated with TB stigma [21]. Except for one study
[22], previous quantitative studies used brief scales that
were not formally developed or not evaluated for inter-
nal consistency [23,24]. Furthermore, each of these
quantitative studies measured TB stigma among patients
only. Given the lack of empirical studies on TB stigma,
it cannot be assumed that stigma levels and associated
factors in patients with TB are identical to the stigma
levels in the community and the factors associated with
community stigma.
We used formally developed and validated scales [25]
to measure the level of TB stigma among patients with
TB and healthy community members. The primary pur-
pose of this study was to test if socio-demographic char-
acteristics, TB knowledge, TB clinical factors, and AIDS
stigma were associated with higher TB stigma among
two different populations: patients with TB and healthy
community members. Identification of factors that affect
stigma, particularly among both groups, would help
inform interventions at the patient, provider, organiza-
tional, and community level.
Methods
Study site and participants
Data for this analysis come from a larger study to measure
TB and AIDS stigma in southern Thailand [12,25] and
identify its effects on care and treatment [26,27]. Adults
(> 17 years old) with TB were enrolled between August
2005 and July 2006 at the regional TB center or one of
seven hospital-based TB clinics (six public and one pri-
vate). Patients were eligible if they had been receiving TB
treatment for less than one month and did not have a
prior history of TB treatment. In April 2007 a convenience
sample of healthy, adult community members were invited
to participate while visiting friends or family members
(admitted for reasons other than TB or AIDS) at two of
the study hospitals. To rule out TB disease among com-
munity participants, individuals were not eligible if they
reported a cough for three weeks or longer.
This study was approved by the Institutional Review
Boards of the University of North Carolina and the Prince
of Songkla University. Written informed consent was
obtained from patients, while community members pro-
vided oral consent.
Stigma measurement
The TB and AIDS stigma scales were developed using
input from patients with TB, patients with AIDS, family
members, and community members and were validated in
a population of patients with TB [12,25]. For this analysis,
TB and AIDS stigma were measured among patients with
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TB using three of these scales: experienced/felt TB stigma
(12 items) measures the experiences, thoughts and feelings
of patients with TB (e.g. “Some people who have TB lose
friends when they share with them they have TB"; “Some
people who have TB feel alone”); perceived TB stigma (11
items) measures the patients’ perception of how commu-
nity members feel about or act toward people who have
TB (e.g. “Some people try not to touch others with TB";
“Some people are afraid of those with TB”); perceived
AIDS stigma (10 items) measures the patient with TB’s
perception of how community members feel about or act
toward people who have AIDS.
We performed a factor analysis to determine if the items
assessing perceived TB and AIDS stigma in patients (e.g.
“Some people try not to touch others with TB”) were also
valid for use in community members. Results showed that
all 11 TB stigma items loaded on a single factor with item
factor loadings between 0.45 and 0.70. All but one of the
original 11 AIDS stigma items loaded on a single factor
with item factor loadings between 0.40 and 0.78. The item
“Some people think that people with AIDS get what they
deserve” had a factor loading < 0.30 and was deleted from
all analyses. When administered to community members,
these scales are referred to as community TB and commu-
nity AIDS stigma scales because they measure how people
in the community feel about or act toward people who
have TB or AIDS. As a result, they compliment the per-
ceived TB and AIDS stigma scales which ask about the
patients’ perception of stigma in the community.
Stigma items were scored on a Likert scale with four
levels: strongly disagree (0), disagree (1), agree (2), and
strongly agree (3). Responses were summed for each
scale to create stigma scores, with higher responses indi-
cating higher stigma. Internal reliability was high for all
four scales, ranging from 0.82 to 0.93. Scores on the
experienced and felt TB stigma scale could range from 0
to 36, scores on the perceived TB and perceived AIDS
stigma scales could range from 0 to 33, and scores on
the community TB and community AIDS scales could
rand from 0 to 30.
Factors potentially associated with TB stigma
Based on review of the published literature, age, gender,
religion, socioeconomic status, TB knowledge, TB symp-
toms (patients only), self-reported HIV status (patients
only), and knowing someone with TB (community mem-
bers only) were considered as potential factors associated
with TB stigma. Information on these factors was collected
by trained interviewers using a questionnaire. Information
on knowing someone with TB was not collected from
patients with TB. Information on HIV status was not col-
lected for community members in an effort to increase
participation. The adult prevalence of HIV in southern
Thailand is low (0.19% among blood donors and 0.59%
among women at ante-natal clinics) [28], which suggests
that community members were likely HIV uninfected.
Analysis
For patients with TB, perceived TB and perceived AIDS
stigma scores were standardized to the age (10 year cate-
gories), gender, religion, and education distribution of the
community members to allow some comparison of stigma
levels reported by patients with TB and community
members.
Confounders of the relationship between each factor
potentially associated with TB stigma and TB stigma
scores were identified using causal diagrams [29,30].
Causal diagrams show the expected or assumed causal
relationships between the independent and dependent
variables and other covariates. They make explicit the a
priori causal knowledge of the investigator necessary to
identify confounders and do not rely on data-driven or
statistical approaches to confounding. Using a series of
graphical rules to assess whether two variables are margin-
ally (in)dependent, a set of adjustment variables sufficient
to control for confounding by measured covariates can be
identified. While the end result is often similar to data dri-
ven approaches, it avoids some shortcomings of those
methods. Continuous TB stigma scores were modeled as
separate outcomes using multivariable linear regression
(SAS 9.1, PROC GENMOD with identity link and normal
distribution), with separate regression models built for
each potential determinant, first among patients with TB,
then among community members (see footnote in Table 1
for the sets of confounders used in each multivariable ana-
lysis). Model coefficients are interpreted as the mean dif-
ference in stigma scores between the index and referent
categories for each factor of interest (socio-demographic
characteristics, TB knowledge, clinical, and AIDS stigma).
Results
Participant characteristics
During the study period, 1,057 adult patients with TB
were registered of whom 929 (88%) were eligible for
participation. Of those who were eligible, 132 (14%) were
too weak or too old to communicate clearly with inter-
viewers and were not enrolled, 317 (34%) refused partici-
pation, and the remaining 480 (52%) were enrolled.
In addition, 300 healthy community members were
enrolled. Compared with community members, patients
tended to be older, less educated, and more often male
and Muslim (Table 2). Infection, smoking, or having a
weak body were common beliefs about the cause of TB
among all participants. Community members also believed
eating or drinking with a person who has TB is a cause of
TB, whereas patients believed working hard can cause TB.
Most participants stated that TB can be transmitted by a
cough or sneeze, but beliefs that transmission occurs
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Table 1 Adjusted differences in mean, summed stigma scores for participant characteristics
Patients with TB Community members
Perceived TB stigma Experienced/felt TB stigma Community TB stigma
Crude* MD† (95% CI) Crude* MD† (95% CI) Crude* MD† (95% CI)
Age Age (per 10 year) 18.12 0.61 (0.29, 0.92) 19.72 0.17 (-0.12, 0.45) 19.96 0.66 (0.22, 1.11)
Gender Male 18.51 0.0 20.16 0.0 19.88 0.0
Female 18.28 0.16 (-0.79, 1.11) 19.28 -0.80 (-1.67, 0.07) 20.37 0.30 (-0.80, 1.39)
Religion Buddhist 18.88 0.0 19.84 0.0 20.02 0.0
Muslim 17.51 -1.37 (-2.32, -0.42) 19.87 0.04 (-0.83, 0.90) 20.59 0.56 (-0.85, 1.98)
Completed secondary 18.44 0.0 19.16 0.0 19.71 0.0
Education Completed primary 17.89 -0.41 (-1.53, 0.72) 19.78 0.54 (-0.46, 1.55) 19.95 0.21 (-1.03, 1.46)
Some or no primary 19.08 0.78 (-0.39, 1.96) 20.52 1.22 (0.17, 2.28) 21.38 1.61 (0.14, 3.08)
Income Baht/month (1,000 baht) 18.38 0.00 (-0.04, 0.03) 19.39 -0.02 (-0.05, 0.02) 19.39 -0.01 (-0.06, 0.04)
Infection from others 18.96 0.0 19.77 0.0 19.81 0.0
Eat/drink with patient 17.58 -1.46 (-3.87, 0.95) 19.20 -0.62 (-2.76, 1.52) 20.42 1.13 (-0.86, 3.11)
TB Knowledge Smoking/drinking 18.62 -0.66 (-1.97, 0.65) 20.49 0.42 (-0.77, 1.62) 20.09 0.03 (-1.57, 1.63)
(Cause) Work hard 17.91 -1.57 (-3.15, 0.01) 19.97 -0.17 (-1.61, 1.28) 24.00 Too few
Heredity 17.79 -0.98 (-3.40, 1.44) 18.65 -1.23 (-3.37, 0.92) 19.44 -1.44 (-3.78, 0.91)
Weak body 18.80 -0.30 (-1.78, 1.17) 19.44 -0.36 (-1.71, 0.99) 20.04 0.43 (-1.84, 2.69)
Not cough or sneeze/don’t know 18.43 0.0 19.67 0.0 20.25 0.0
Cough/sneeze 18.43 0.08 (-1.09, 1.25) 19.89 0.40 (-0.67, 1.47) 20.09 -0.28 (-1.51, 0.95)
Not eat or drink/don’t know 18.15 0.0 19.61 0.0 19.41 0.0
TB Knowledge Eat/drink 18.61 0.52 (-0.39, 1.43) 20.01 0.44 (-0.39, 1.26) 21.39 1.73 (0.62, 2.84)
(Transmission) Not touch/don’t know 18.43 0.0 19.74 0.0 20.12 0.0
Touch 18.49 -0.14 (-1.73, 1.45) 21.00 1.21 (-0.22, 2.64) 20.22 -0.33 (-2.17, 1.51)
Not set/don’t know 18.33 0.0 19.75 0.0 20.05 0.0
Sex 19.35 1.06 (-0.44, 2.55) 20.84 0.92 (-0.46, 2.30) 21.63 1.94 (-0.47, 4.34)
TB Knowledge Not curable 19.63 0.0 20.67 0.0 20.65 0.0
(Cure) Curable 18.39 -1.41 (-3.84, 1.02) 19.83 -0.91 (-3.17, 1.35) 19.97 -0.93 (-2.23, 0.37)
TB does not increase AIDS/don’t know 17.84 0.0 18.74 0.0 19.87 0.0
TB increases AIDS 19.02 1.08 (0.19, 1.86) 20.93 2.16 (1.38, 2.94) 20.42 0.55 (-0.52, 1.62)
TB Knowledge‡ AIDS does not increase TB/don’t know 18.12 0.0 19.37 0.0 19.52 0.0
(TB/HIV) AIDS increases TB 18.55 0.42 (-0.59, 1.42) 20.03 0.85 (-0.07, 1.77) 20.36 0.86 (-0.35, 2.06)
AIDS and TB do not appear similar 17.83 0.0 19.15 0.0 20.52 0.0
AIDS/TB appear similar 18.68 0.86 (-0.12, 1.84) 20.14 0.86 (-0.03, 1.75) 19.89 -0.55 (-1.66, 0.57)
HIV/AIDS stigma Perceived/Community AIDS stigma 19.79 0.64 (0.58, 0.71) 21.79 0.48 (0.41, 0.55) 21.00 0.55 (0.45, 0.64)
Know person Did not know person with TB 19.75 0.0
with TB Knew person with TB (lived) 19.98 0.13 (-1.32, 1.57)
Knew person with TB (died) 22.42 2.59 (0.96, 4.22)
Never tested 18.42 0.0 19.72 0.0
HIV status§ Previously tested negative 18.17 0.04 (-1.05, 1.13) 19.44 -0.05 (-1.04, 1.94)
Previously tested positive 18.91 0.90 (-0.42, 2.22) 21.09 1.57 (0.39, 2.76)
Cough 18.70 0.0 19.98 0.0
Hemoptysis 18.25 -0.43 (-1.54, 0.69) 19.48 -0.57 (-1.57, 0.42)
Symptoms§‡ Weight loss 18.57 -0.28 (-1.78, 1.22) 20.79 0.48 (-0.89, 1.85)
Fever and/or EPTB only 17.04 -1.61 (-3.11,-0.10) 19.17 -0.51 (-1.85, 0.83)
No symptoms 20.36 1.73 (-0.94, 4.40) 19.77 -0.18 (-2.64, 2.28)
*Crude, mean stigma scores for each group. For continuous variables, mean stigma scores are reported for ages 30 to 39 years old, those with 10,000 baht
income, and AIDS stigma scores of 20.
† MD, adjusted mean difference in summed stigma scores; CI, confidence interval; 0.0 indicates referent level. Sets of confounders used in multivariable analysis
of each factor are as follows:
Age and Religion: no confounders; Gender: adjusted for age and religion; Income: adjusted for age, religion and education; Education: adjusted for religion and gender;
TB knowledge variables: adjusted for age, education, income (patients only) and knowing someone with TB (community members only); AIDS stigma: adjusted for age,
gender, religion, education, income, TB/HIV knowledge, HIV status (patients only) and TB symptoms (patients only); Knowing someone with TB (community members
only): adjusted for age and income; HIV status (patients only): adjusted for age, religion and income; TB symptoms (patients only): adjusted for gender and HIV status
‡ Cough and hemoptysis categories may also include patients with additional symptoms such as weight loss, fever, or EPTB (extrapulmonary TB); Weight loss
excludes cough but may include other symptoms (e.g. fever and/or EPTB); Fever and EPTB includes patients with only those symptoms (no cough or weight loss).
§ Self-reported
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through routes such as eating and drinking with a person
who has TB were also common, especially among patients.
Nearly all patients and most community members knew
TB was curable. High awareness of a link between TB and
HIV was present among all participants.
Most patients reported symptoms typically associated
with TB. Upon diagnosis of TB, 73 (15.2%) patients
were aware of their HIV co-infection and 115 (24%)
had a negative test in the past. The majority (292;
60.8%), however, had never been tested for HIV.
Among community members, 89 (29.7%) knew one or
more persons who suffered from TB regardless of out-
come, while 38 (12.7%) knew someone who had died
from TB.
Table 2 Distribution of participant characteristics
Continuous participant characteristics Patients with TB Community members
Age Age in years (median, range) 37 (18 - 79) 34 (18 - 69)
Income Thousand Baht per month (median, range) 10 (0 - 90) 10 (1 - 100)
Categorical participant characteristics N (%) N (%)
Gender Male 317 (66.0) 146 (48.7)
Female 163 (34.0) 154 (51.3)
Religion Buddhist 319 (66.7) 244 (81.3)
Muslim 159 (33.3) 56 (18.7)
Education Less than or no primary school 160 (33.4) 61 (20.3)
Completed primary school 191 (39.8) 103 (34.3)
Completed secondary school 129 (26.9) 136 (45.3)
TB knowledge* Infected from family/others 87 (18.1) 42 (14.0)
(Cause) Work hard 71 (14.8) 3 (1.0)
Smoking/drinking 162 (33.8) 158 (52.7)
Heredity 20 (4.2) 25 (8.3)
Weak body 82 (17.1) 27 (9.0)
Eat or drink with patient 20 (4.2) 43 (14.3)
Other 38 (7.9) 2 (0.7)
TB knowledge† Eat/drink 291 (61.9) 109 (36.7)
(Transmission) Touch 41 (8.7) 32 (10.8)
Sex 46 (9.8) 16 (5.4)
Cough/sneeze 396 (84.3) 224 (75.4)
Other 64 (13.6) 50 (16.8)
TB knowledge Curable 463 (96.5) 231 (77.0)
(Cure) Not curable 17 (3.5) 69 (23.0)
TB knowledge† TB increase AIDS 242 (50.4) 142 (47.3)
(TB/HIV) AIDS increases TB 346 (72.1) 219 (73.0)
AIDS/TB appear similar 339 (70.6) 186 (62.0)
Knew person Did not know person with TB 211 (70.3)
with TB Knew person with TB (lived) 51 (17.0)
Knew person with TB (died) 38 (12.7)
HIV status‡ Never tested 292 (60.8)
Previously tested negative 115 (24.0)
Previously tested positive 73 (15.2)
Symptoms§ Cough 236 (49.2)
Hemoptysis 116 (24.2)
Weight loss 59 (12.3)
Fever and/or extrapulmonary only 55 (11.5)
No symptoms 14 (2.9)
* Exclusive or † non-exclusive categories
§ Cough and hemoptysis categories may also include patients with additional symptoms such as weight loss, fever, or EPTB (extrapulmonary TB); Weight loss
excludes cough but may include other symptoms (e.g. fever and/or EPTB); Fever and EPTB includes patients with only those symptoms (no cough or weight loss).
‡Self-reported
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Stigma scale responses
On the TB stigma scales, 14 (2.9%) and 20 (4.2%)
patients were excluded from the perceived stigma and
experienced/felt stigma scale analyses, respectively, due
to missing item responses. On the perceived AIDS
stigma scale, 15 (3.1%) patients had missing item
responses. All community members had complete item
responses. Internal consistency (Cronbach’s coefficient
alpha) for all three scales was good (range 0.82 to 0.91)
and all scores were normally distributed with mean
scores ranging from 17.20 to 20.13 (Table 3).
The mean community TB stigma score was higher than
the mean perceived TB stigma score reported by patients
(20.13 vs.18.43 or 18.25 after standardization and exclu-
sion of patients with known HIV infection). The mean
community AIDS stigma score was also higher than the
mean perceived AIDS stigma score reported by patients
with TB, (19.14 vs. 17.20 or 16.90 after standardization
and exclusion of patients with known HIV infection). In
both groups, AIDS stigma scores were only slightly higher
than TB stigma scores.
Factors associated with TB stigma
Mean differences (MD) in TB stigma scores between
index and referent levels of each factor potentially asso-
ciated with TB stigma were small (Table 1), with 75% of
estimates having less than a one point difference in
stigma score. Only two estimates were greater than a two
point difference in stigma score. Believing that TB
increases the chance of getting AIDS was associated with
experienced/felt TB stigma among patients (MD 2.16;
95% CI: 1.38, 2.94) and knowing someone who died of
TB was associated with community TB stigma among
community members (2.59; 95% CI: 0.96, 4.22).
Factors associated with TB stigma among patients with
TB. Few factors had consistent MDs in stigma scores for
both the perceived TB stigma and experienced/felt TB
stigma scales.. Older age (0.66; 0.22, 1.11 per 10 year
increase) and Muslim religion (-1.37; 95% CI: -2.32,
-0.42) were both associated with perceived TB stigma,
while being female (-0.80; 95% CI: -1.67, 0.07) was only
associated with experienced/felt TB stigma. Patients with
some or no primary education reported higher scores on
both TB stigma scales, especially the experienced/felt
stigma scale (1.22; 95% CI: 0.17, 2.28), compared to
patients who completed secondary education. Patients
who reported incorrect beliefs about the cause of TB
consistently had lower scores on both TB stigma scales
than patients who knew that infection was the cause of
TB, but all estimates were imprecise. There was also no
association between knowledge about TB transmission or
believing TB was curable and TB stigma.
Knowledge and clinical factors related to HIV/AIDS
tended to be associated with higher TB stigma. Correctly
knowing that AIDS increases the likelihood of developing
TB and that both AIDS and TB symptoms appear similar
was associated with slightly higher scores on both TB
stigma scales. Patients who believed that having TB could
increase the likelihood of having AIDS reported much
higher scores on the perceived TB stigma scale (1.08; 95%
CI: 0.19, 1.86) and the experienced/felt TB stigma scale
(2.16; 95% CI: 1.38, 2.94). Similarly, patients reporting
higher perceived AIDS stigma also had higher scores on
the perceived TB stigma scale (0.64; 95% CI: 0.58, 0.71 per
one point increase in the AIDS stigma score) and the
experienced/felt TB stigma scale (0.48; 95% CI: 0.41, 0.55).
Patients who were aware of their HIV co-infection prior to
study enrollment had higher stigma scores, especially on
the experienced/felt TB stigma scale (1.57; 95% CI: 0.39,
2.76) compared to those who had never been tested. In
contrast, patients presenting with fever only or extrapul-
monary symptoms, presentations which are more com-
mon among HIV-infected patients with TB, had lower
stigma, especially on the perceived TB stigma scale (-1.61;
95% CI: -3.11, -0.10).
Factors associated with TB stigma among community
members. Similar to patients with TB, both older age
(0.66; 95% CI: 0.22, 1.11) and having some or no primary
education (1.61; 95% CI: 0.14, 3.08) were associated with
higher community TB stigma scores. Knowledge of TB
did not show any association with community TB stigma,
except for believing that TB can be transmitted though
eating and drinking with a patient (1.73; 95% CI: 0.62,
2.84). Unlike the results for patients with TB, there was
Table 3 Stigma scale characteristics and scores
Cronbach’s
alpha
Mean summed
stigma score (SD)
Kurtosis Skewness
Tuberculosis stigma
Patients with TB: experienced and felt TB stigma (12 items) 0.82 19.85 (4.43) 1.35 0.00
Patients with TB: perceived TB stigma (11 items) 0.88 18.43 (4.95) 0.36 -0.06
Community members: community TB stigma (11 items) 0.85 20.13 (4.87) 0.31 0.08
AIDS stigma
Patients with TB: perceived AIDS stigma (10 items) 0.91 17.20 (4.88) 0.65 -0.35
Community members: community AIDS stigma (10 items) 0.87 19.14 (4.86) 0.46 -0.12
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no association between TB/HIV knowledge and TB
stigma. Reporting higher community AIDS stigma, how-
ever, was associated with higher community TB stigma
(0.55; 95% CI: 0.45, 0.64 per one point increase). Know-
ing someone who died of TB was also associated with
higher community TB stigma (2.59; 95% CI: 0.96, 4.22)
compared with not knowing anyone with TB.
Discussion
Most factors analyzed in this study had only minimal or
inconsistent associations with TB stigma. Only poor edu-
cation (some or no primary education) and AIDS stigma
showed a consistent association with higher TB stigma in
all three analyses. In addition to low levels of formal educa-
tion, the largest, most precise, and consistent associations
with higher TB stigma were beliefs relating to the intersec-
tion of TB with HIV, HIV co-infection, and the level of
AIDS stigma. Knowing someone who died of TB had the
largest association with TB stigma. Individuals in areas
affected by HIV are more likely to believe that TB is not
curable [13,22]. Thus, higher TB stigma due to knowing
someone who has died of TB may be linked to HIV co-
infection via the belief that TB is not curable, a result that
was observed, but not statistically supported, in our study.
Most prior studies on TB stigma have been qualitative.
A qualitative study in the same area of southern Thailand
found that religion, low TB knowledge, severe symptoms,
and symptoms similar to AIDS were related to stigmatiz-
ing attitudes towards TB [12]. While some of these quali-
tative observations were confirmed by our quantitative
findings, most factors identified as being associated with
TB stigma in the qualitative study showed small, inconsis-
tent or imprecise effects in our study. Only among com-
munity members was the belief that eating and drinking
with a patient could transmit TB found to be associated
with a larger increase in stigma. These studies underscore
the importance of quantitative analyses to assess the gen-
eralizability and magnitude of associations observed in
qualitative studies.
To date, only three other quantitative studies of TB
stigma and potential factors associated with TB stigma
have been published [22-24]. Detailed comparisons
between them warrant caution, as different scales, study
populations, and potential factors were used. Similar to our
findings, however, lack of consistent associations between
factors and stigma among different populations was
observed by Somma et al.[22] from a study in Bangladesh,
India, Malawi and Colombia. In that study, only marital
status, financial problems, social distress, and seeking care
at a private hospital were found to increase stigma in more
than one study site.
Documenting the level of TB stigma and identifying
factors associated with stigma are important steps
towards developing interventions to reduce stigma [4].
It is generally believed that increasing TB knowledge and
education are important interventions to decrease stigma
[8,31]. We found, however, that TB knowledge itself has
a minor and inconsistent association with TB stigma. We
did find that incorrectly believing TB can increase the
chance of getting AIDS was associated with higher stigma
among patients. This is most likely due to the rate of TB/
HIV co-infection and/or that patients with TB are routi-
nely tested for HIV. Thus, having TB increases the
chances of being diagnosed with, but not being infected
with, HIV. In our study, belief that TB increases the
chance of getting AIDS, AIDS stigma, co-infection with
HIV, and knowing someone who died from TB had the
strongest, most precise, and most consistent association
with higher TB stigma. This is consistent with the sug-
gestion that AIDS and AIDS stigma may compound
existing TB stigma [13,18,19] and suggests that interven-
tions aimed at decreasing TB stigma should also address
the HIV/AIDS epidemic. This may include media and
public education campaigns to raise awareness that TB
occurs and is curable, both in HIV-infected individuals
and those not infected with HIV. This could coincide
with the message that people living with HIV should be
watchful for symptoms of TB and seek medical care if
they develop common TB symptoms, with making
HAART available to all patients needing treatment for
HIV, and providing isoniazid preventive therapy (IPT) to
patients with HIV. It has been suggested that scaling up
the provision of HAART may decrease AIDS stigma by
reducing AIDS mortality and allowing for normalization
of patients [32-34], while provision of IPT would reduce
the burden of HIV-related TB morbidity and mortality,
thereby changing the perception that patients with HIV
also develop TB [35-37].
Some limitations of our study should be noted. First, the
small number of responses for some causes and transmis-
sion routes of TB could have led to low power to detect a
true association with stigma. Second, it is possible that
associations were biased as high levels of stigma may have
caused patients to avoid seeking any care for their symp-
toms, high levels of stigma may have been the reason why
some eligible patients refused to participate in the study,
or a period of coping could have occurred between the
onset of symptoms and presentation at the clinic, resulting
in lower levels of stigma. This could explain, in part, why
patients with TB reported lower TB and AIDS stigma than
community members, because there is no reason to think
any selection bias occurred among community members.
Finally, we did not assess factors associated with stigma
during TB treatment.
Conclusion
Few quantitative studies on TB stigma and potential fac-
tors associated with TB stigma have been published.
Kipp et al. BMC Public Health 2011, 11:675
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We report the presence of TB stigma in both patients
and community members in southern Thailand. Our
results suggest that interventions addressing the dual
TB/HIV epidemic may be needed to combat TB stigma,
and that simply improving knowledge about TB may
have limited effects.
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